Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
M.B.B.S, F.C.P.S. (Medicine)
Internal Medicine Specialist
M.B.B.S, F.C.P.S. (Medicine)
Internal Medicine Specialist
MBBS, MD (Internal Medicine)
Gastroenterologist
M.D, F.C.P.S (Gastroenterology)
Internal Medicine Specialist
MBBS, Specialty Certificate in Endocrine and Diabetes, MRCP (Dublin), MRCP (London)
Internal Medicine Specialist
MBBS, Specialty Certificate in Endocrine and Diabetes, MRCP (Dublin), MRCP (London)
Internal Medicine Specialist
MBBS, FCPS (Medicine), Diploma in Family Medicine, FRCP Gladgow (UK)
Internal Medicine Specialist
MBBS, FCPS (Medicine), Diploma in Family Medicine, FRCP Gladgow (UK)
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine), M.R.C.P. ( . )
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine), M.R.C.P. ( . )
Diabetologist
MBBS, M.Phil, Ph.D
Gastroenterologist
MBBS, FCPS (Gastroenterology)
Internal Medicine Specialist
M.B.B.S., M.D.
Internal Medicine Specialist
MBBS, M.D (Medicine), M.D Nephrology (Gold Medlist), ESENeph
Internal Medicine Specialist
MBBS, M.D (Medicine), M.D Nephrology (Gold Medlist), ESENeph
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures